{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:32:55Z","timestamp":1786116775453,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52790-3","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:18:06Z","timestamp":1779877086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of IDH1 promoter methylation and associated genome-wide alterations in breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Summayya","family":"Anwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Yasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qurat","family":"Ulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfar","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erum","family":"Najeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza Imran","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5998-787X","authenticated-orcid":false,"given":"Muhammad","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"52790_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J Clin."},{"key":"52790_CR2","doi-asserted-by":"publisher","first-page":"e0134687","DOI":"10.1371\/journal.pone.0134687","volume":"10","author":"F Ullah","year":"2015","unstructured":"Ullah, F. et al. Promoter methylation status modulate the expression of tumor suppressor (RbL2\/p130) gene in breast cancer. PLoS ONE 10, e0134687. https:\/\/doi.org\/10.1371\/journal.pone.0134687 (2015).","journal-title":"PLoS ONE"},{"key":"52790_CR3","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.7314\/APJCP.2013.14.3.2255","volume":"14","author":"ZNN Khan","year":"2013","unstructured":"Khan, Z. N. N., Sabir, M., Kayani, MAa. & Saeed, M. Acetylation of Retinoblastoma Like Protein2 (Rb2\/p130) in tumor tissues. Asian Pac. J. Cancer Prev. 14, 2255\u20132258. https:\/\/doi.org\/10.7314\/APJCP.2013.14.3.2255 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"52790_CR4","doi-asserted-by":"publisher","first-page":"a019505","DOI":"10.1101\/cshperspect.a019505","volume":"8","author":"SB Baylin","year":"2016","unstructured":"Baylin, S. B. & Jones, P. A. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 8, a019505. https:\/\/doi.org\/10.1101\/cshperspect.a019505 (2016).","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"52790_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pharmthera.2015.05.003","volume":"152","author":"SJ Parker","year":"2015","unstructured":"Parker, S. J. & Metallo, C. M. Metabolic consequences of oncogenic IDH mutations. Pharmacol. Ther. 152, 54\u201362. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.05.003 (2015).","journal-title":"Pharmacol. Ther."},{"key":"52790_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739\u2013744. https:\/\/doi.org\/10.1038\/nature08617 (2009).","journal-title":"Nature"},{"key":"52790_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11060-018-2845-1","volume":"139","author":"KB Salom\u00e3o","year":"2018","unstructured":"Salom\u00e3o, K. B. et al. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. J. Neurooncol. 139, 33\u201342. https:\/\/doi.org\/10.1007\/s11060-018-2845-1 (2018).","journal-title":"J. Neurooncol."},{"key":"52790_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45346-1","author":"D Unruh","year":"2019","unstructured":"Unruh, D. et al. Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-019-45346-1 (2019).","journal-title":"Sci. Rep."},{"key":"52790_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241271714\/SUPPL_FILE\/SJ-PDF-1-CCX-10.1177_10732748241271714.PDF","author":"T Ali","year":"2024","unstructured":"Ali, T. et al. Aberrant HIF1- \u03b1 and SIX-1 expression is associated with poor prognosis in acute myeloid leukemia patients with isocitrate dehydrogenase 1 mutations. Cancer Control https:\/\/doi.org\/10.1177\/10732748241271714\/SUPPL_FILE\/SJ-PDF-1-CCX-10.1177_10732748241271714.PDF (2024).","journal-title":"Cancer Control"},{"key":"52790_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-0953-7","author":"W-S Liu","year":"2018","unstructured":"Liu, W.-S. et al. Isocitrate dehydrogenase 1\u2013snail axis dysfunction significantly correlates with breast cancer prognosis and regulates cell invasion ability. Breast Cancer Res. https:\/\/doi.org\/10.1186\/s13058-018-0953-7 (2018).","journal-title":"Breast Cancer Res."},{"key":"52790_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/1071576021000050429","author":"SY Kim","year":"2003","unstructured":"Kim, S. Y. & Park, J. W. Cellular defense against singlet oxygen-induced oxidative damage by cytosolic NADP+-dependent isocitrate dehydrogenase. Free Radical Res. https:\/\/doi.org\/10.1080\/1071576021000050429 (2003).","journal-title":"Free Radical Res."},{"key":"52790_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53262-7","author":"R Bledea","year":"2019","unstructured":"Bledea, R. et al. Functional and topographic effects on DNA methylation in IDH1\/2 mutant cancers. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-019-53262-7 (2019).","journal-title":"Sci. Rep."},{"key":"52790_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00193","author":"S Flanagan","year":"2012","unstructured":"Flanagan, S., Lee, M., Li, C. C. Y., Suter, C. M. & Buckland, M. E. Promoter Methylation Analysis of IDH Genes in Human Gliomas. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2012.00193 (2012).","journal-title":"Front. Oncol."},{"key":"52790_CR14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/BIOINFORMATICS\/18.11.1427","volume":"18","author":"LC Li","year":"2002","unstructured":"Li, L. C. & Dahiya, R. MethPrimer: Designing primers for methylation PCRs. Bioinformatics 18, 1427\u20131431. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/18.11.1427 (2002).","journal-title":"Bioinformatics"},{"key":"52790_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","volume":"583","author":"F Abascal","year":"2020","unstructured":"Abascal, F. et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature 583, 699\u2013710. https:\/\/doi.org\/10.1038\/s41586-020-2493-4 (2020).","journal-title":"Nature"},{"key":"52790_CR16","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/NAR\/GKV1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71. https:\/\/doi.org\/10.1093\/NAR\/GKV1507 (2016).","journal-title":"Nucleic Acids Res."},{"key":"52790_CR17","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1093\/NAR\/GKW967","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou, W., Laird, P. W. & Shen, H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 45, e22. https:\/\/doi.org\/10.1093\/NAR\/GKW967 (2017).","journal-title":"Nucleic Acids Res."},{"key":"52790_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/NAR\/GKV007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47. https:\/\/doi.org\/10.1093\/NAR\/GKV007 (2015).","journal-title":"Nucleic Acids Res."},{"key":"52790_CR19","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1093\/BIOINFORMATICS\/BTZ096","volume":"35","author":"J Martorell-Marug\u00e1n","year":"2019","unstructured":"Martorell-Marug\u00e1n, J., Gonz\u00e1lez-Rumayor, V. & Carmona-S\u00e1ez, P. mCSEA: Detecting subtle differentially methylated regions. Bioinformatics 35, 3257\u20133262. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTZ096 (2019).","journal-title":"Bioinformatics"},{"key":"52790_CR20","unstructured":"Cs\u00e1rdi, G., Nepusz, T. The igraph software package for complex network research. (2006)."},{"key":"52790_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.982424","author":"W Tian","year":"2022","unstructured":"Tian, W. et al. Recent advances of IDH1 mutant inhibitor in cancer therapy. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.982424 (2022).","journal-title":"Front. Pharmacol."},{"key":"52790_CR22","doi-asserted-by":"publisher","first-page":"e0266196","DOI":"10.1371\/journal.pone.0266196","volume":"17","author":"F Ullah","year":"2022","unstructured":"Ullah, F., Khurshid, N., Fatimi, Q., Loidl, P. & Saeed, M. Mutations in the acetylation hotspots of Rbl2 are associated with increased risk of breast cancer. PLoS ONE 17, e0266196. https:\/\/doi.org\/10.1371\/journal.pone.0266196 (2022).","journal-title":"PLoS ONE"},{"key":"52790_CR23","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2016.19.2.133","author":"A Ali","year":"2016","unstructured":"Ali, A. et al. Aberrant promoter methylation at CpG cytosines induce the upregulation of the E2F5 gene in breast cancer. J. Breast Cancer. https:\/\/doi.org\/10.4048\/jbc.2016.19.2.133 (2016).","journal-title":"J. Breast Cancer."},{"key":"52790_CR24","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8382","author":"FU Farman","year":"2018","unstructured":"Farman, F. U. et al. Aberrant promoter methylation status is associated with upregulation of the E2F4 gene in breast cancer. Oncol. Lett. https:\/\/doi.org\/10.3892\/ol.2018.8382 (2018).","journal-title":"Oncol. Lett."},{"key":"52790_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.1170944","author":"S Zhao","year":"2009","unstructured":"Zhao, S. et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1\u03b1. Science (1979) https:\/\/doi.org\/10.1126\/science.1170944 (2009).","journal-title":"Science (1979)"},{"key":"52790_CR26","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1111\/jcmm.15185","volume":"24","author":"L Zhu","year":"2020","unstructured":"Zhu, L. et al. Increased SIX\u20101 expression promotes breast cancer metastasis by regulating lncATB\u2010miR\u2010200s\u2010ZEB1 axis. J. Cell Mol. Med. 24, 5290\u20135303. https:\/\/doi.org\/10.1111\/jcmm.15185 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"52790_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04679-2","author":"L Guo","year":"2023","unstructured":"Guo, L. et al. SIX1 amplification modulates stemness and tumorigenesis in breast cancer. J. Transl. Med. https:\/\/doi.org\/10.1186\/s12967-023-04679-2 (2023).","journal-title":"J. Transl. Med."},{"key":"52790_CR28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/J.MOLMED.2024.04.017","volume":"30","author":"P Shahrouzi","year":"2024","unstructured":"Shahrouzi, P., Forouz, F., Mathelier, A., Kristensen, V. N. & Duijf, P. H. G. Copy number alterations: A catastrophic orchestration of the breast cancer genome. Trends Mol. Med. 30, 750\u2013764. https:\/\/doi.org\/10.1016\/J.MOLMED.2024.04.017 (2024).","journal-title":"Trends Mol. Med."},{"issue":"1","key":"52790_CR29","doi-asserted-by":"publisher","first-page":"14-","DOI":"10.1038\/s41525-023-00361-0","volume":"8","author":"T Brewer","year":"2023","unstructured":"Brewer, T., Yehia, L., Bazeley, P. & Eng, C. Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome. Npj. Genom. Med. 8(1), 14-. https:\/\/doi.org\/10.1038\/s41525-023-00361-0 (2023).","journal-title":"Npj. Genom. Med."},{"key":"52790_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.14348\/MOLCELLS.2016.0150","volume":"39","author":"YE Kim","year":"2016","unstructured":"Kim, Y. E. et al. Transforming growth factor-\u03b2-induced RBFOX3 inhibition promotes epithelial-mesenchymal transition of lung cancer cells. Mol. Cells 39, 625\u2013630. https:\/\/doi.org\/10.14348\/MOLCELLS.2016.0150 (2016).","journal-title":"Mol. Cells"},{"key":"52790_CR31","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.7150\/THNO.19506","volume":"7","author":"T Liu","year":"2017","unstructured":"Liu, T. et al. RBFOX3 promotes tumor growth and progression via hTERT signaling and predicts a poor prognosis in hepatocellular carcinoma. Theranostics 7, 3138. https:\/\/doi.org\/10.7150\/THNO.19506 (2017).","journal-title":"Theranostics"},{"key":"52790_CR32","doi-asserted-by":"publisher","first-page":"e0164164","DOI":"10.1371\/JOURNAL.PONE.0164164","volume":"11","author":"YS Lin","year":"2016","unstructured":"Lin, Y. S. et al. Neuronal splicing regulator RBFOX3 (NeuN) regulates adult hippocampal neurogenesis and synaptogenesis. PLoS ONE 11, e0164164. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0164164 (2016).","journal-title":"PLoS ONE"},{"issue":"1","key":"52790_CR33","doi-asserted-by":"publisher","first-page":"6647-","DOI":"10.1038\/s41598-024-55917-6","volume":"14","author":"D Mustafov","year":"2024","unstructured":"Mustafov, D., Siddiqui, S. S., Klena, L., Karteris, E. & Braoudaki, M. SV2B\/miR-34a\/miR-128 axis as prognostic biomarker in glioblastoma multiforme. Sci. Rep. 14(1), 6647-. https:\/\/doi.org\/10.1038\/s41598-024-55917-6 (2024).","journal-title":"Sci. Rep."},{"key":"52790_CR34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41417-022-00571-1","volume":"30","author":"L Siculella","year":"2022","unstructured":"Siculella, L. et al. A comprehensive understanding of hnRNP A1 role in cancer: new perspectives on binding with noncoding RNA. Cancer Gene Ther. 30, 394\u2013403. https:\/\/doi.org\/10.1038\/s41417-022-00571-1 (2022).","journal-title":"Cancer Gene Ther."},{"key":"52790_CR35","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.7150\/THNO.113312","volume":"15","author":"X Wang","year":"2025","unstructured":"Wang, X. et al. Old players and new insights: unraveling the role of RNA-binding proteins in brain tumors. Theranostics. 15, 5238\u20135257. https:\/\/doi.org\/10.7150\/THNO.113312 (2025).","journal-title":"Theranostics."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52790-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52790-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52790-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:04:25Z","timestamp":1786017865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52790-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52790"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52790-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and institutional ethical guidelines. The protocol was approved by the COMSATS University Islamabad Ethical Review Board (Approval No. CUI\/Bio\/ERB\/2017\/23), and written informed consent was obtained from all participants before sample collection.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24242"}}